Form 8.3 - AGI Therapeutics Plc (9231V)

TIDMAGI

RNS Number : 9231V

Peel Hunt LLP

20 January 2012

 
                                FORM 8.3 
 
                           IRISH TAKEOVER PANEL 
 
                  DISCLOSURE UNDER RULE 8.3 OF THE IRISH 
                    TAKEOVER PANEL ACT, 1997, TAKEOVER 
                         RULES, 2007 (AS AMENDED) 
 
                    DEALINGS BY PERSONS WITH INTERESTS 
                   IN RELEVANT SECURITIES REPRESENTING 
                                1% OR MORE 
 
                            1. KEY INFORMATION 
================================================================= 
Name of person dealing          Peel Hunt LLP 
 (Note 1) 
=============================  ================================== 
Company dealt in                AGI Therapeutics 
                                 Plc 
=============================  ================================== 
Class of relevant              Ordinary Shares of 
 security to which              EUR0.01 each 
 the dealings being 
 disclosed relate 
 (Note 2) 
=============================  ================================== 
Date of dealing                 19 January 2012 
=============================  ================================== 
 
 
  2. INTERESTS AND SHORT POSITIONS 
 
  (a) Interests and short positions 
  (following dealing) in the class of 
  relevant security dealt in (Note 3) 
================================================================= 
                                          Long              Short 
=============================  ===============  ================= 
                               Number (%)        Number (%) 
=============================  ===============  ================= 
                               2,813,219 
(1) Relevant securities         (4.17%) 
=============================  ===============  ================= 
(2) Derivatives 
 (other than options) 
=============================  ===============  ================= 
(3) Options and 
 agreements to purchase/sell 
=============================  ===============  ================= 
                               2,813,219 
Total                           (4.17%) 
=============================  ===============  ================= 
 (b) Interests and short positions 
  in relevant securities of the company, 
  other than the class dealt in (Note 
  3) 
================================================================= 
Class of relevant                         Long              Short 
 security: 
=============================  ===============  ================= 
                               Number (%)        Number (%) 
=============================  ===============  ================= 
 
 (1) Relevant securities 
=============================  ===============  ================= 
 
 (2) Derivatives 
 (other than options) 
=============================  ===============  ================= 
 
 (3) Options and 
 agreements to purchase/sell 
=============================  ===============  ================= 
 
 Total 
=============================  ===============  ================= 
 
 
 
 
                                                  1 February 2009 
 
 
 
3. DEALINGS (Note 4) 
 
 (a) Purchases and sales 
========================================================================================================= 
 
 Purchase/sale                Number of relevant                          Price per 
                              securities                                  unit (Note 
                                                                          5) 
====================  =============================================  ==================================== 
Purchase              50,000                                         6.68388 
====================  =============================================  ==================================== 
 
 
 (b) Derivatives transactions (other 
 than options transactions) 
========================================================================================================= 
Product 
 name,                Nature of         Number of relevant                         Price 
 e.g. CFD             transaction       securities                                 per unit 
 
                      (Note 6)          (Note 7)                                   (Note 
                                                                                   5) 
===================  ================  ========================================  ======================== 
 
 
 
 (c) Options transactions in respect 
 of existing relevant securities 
 
 (i) Writing, selling, purchasing 
 or varying 
========================================================================================================= 
Product             Writing,           Number           Exercise     Type,       Expiry  Option 
 name,              selling,           of securities     price       e.g.        date     money 
 e.g.               purchasing,        to which                      American,            paid/received 
 call               varying            the option                    European             per 
 option             etc.               relates                       etc.                 unit 
                                       (Note                                              (Note 
                                       7)                                                 5) 
==================  =================  ==============  ============  ==========  ======  ================ 
 
 
 
 
 (ii) Exercising 
========================================================================================================= 
Product name,                Number of securities                        Exercise 
 e.g. call                                                                price per 
 option                                                                   unit (Note 
                                                                          5) 
====================  =============================================  ==================================== 
 
 
 
 
 (d) Other dealings (including transactions 
 in respect of new securities) (Note 
 4) 
========================================================================================================= 
Nature of                    Details                                     Price per 
 transaction                                                              unit 
 (Note 8)                                                                 (if applicable) 
                                                                          (Note 5) 
====================  =============================================  ==================================== 
 
 
 
 
 
 
 
                                                                                          1 February 2009 
 
 
 
4. OTHER INFORMATION 
 
 Agreements, arrangements or understandings 
 relating to options or derivatives 
============================================== 
Full details of any agreement, arrangement 
 or understanding between the person 
 disclosing and any other person relating 
 to the voting rights of any relevant 
 securities under any option referred 
 to on this form or relating to the 
 voting rights or future acquisition 
 or disposal of any relevant securities 
 to which any derivative referred to 
 on this form is referenced. If none, 
 this should be stated. 
============================================== 
 
 
 
 
 Is a Supplemental Form 8 attached? 
 (Note 9) YES/NO 
============================================== 
Date of disclosure             20 January 2012 
=============================  =============== 
Contact name                    Kelly Morgan 
=============================  =============== 
Telephone number                0207 418 8860 
=============================  =============== 
If a connected EFM,            N/A 
 name of offeree/offeror 
 with which connected 
=============================  =============== 
If a connected EFM,            N/A 
 state nature of connection 
 (Note 10) 
=============================  =============== 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                               1 February 2009 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RETLLFLLLIIIFIF